Anbio Biotechnology
anbiobiotechnology.comWhat Do They Do?
Supplies in vitro diagnostic tests, instruments and reagents for laboratories, point-of-care settings, and over-the-counter use by healthcare providers and patients.
20-F for FY2025, filed Apr 7, 2026Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our…View ↗
Anbio collaborates with third-party laboratories to develop in vitro diagnostic (IVD) products tailored for laboratory, point-of-care…View ↗
Anbio develops IVD assays that utilizes established and widely used IVD technology platforms and their scientific principles. Our product…View ↗
How Do They Make Money?
Customers pay for diagnostic products when the products ship; payment terms vary by customer contract.
20-F for FY2025, filed Apr 7, 2026Revenue from product sales is recognized at the point in time control of the products is transferred, generally upon the shipping point.…View ↗
$8.6M
-
20-F for FY2025, filed Apr 7, 2026
$8.6M ↗
Who Are Their Customers?
Sells mainly business-to-business through distributors and its direct sales team. Laboratories may buy directly from the company or through distributors; its sales efforts also target government agencies and healthcare providers such as hospitals and clinics.
20-F for FY2025, filed Apr 7, 2026
20-F for FY2025, filed Apr 7, 2026
Do Revenues Turn Into Profits?
Yes. It kept 74 cents of every revenue dollar as net income in FY2025.
20-F for FY2025, filed Apr 7, 2026
Loading...
